1. 1. World Health Organization (WHO). Novel coronavirus (2019-nCoV) situation report-1. Available at <https://apps.who.int/iris/handle/10665/330760>. Accessed January 21, 2020.
2. 2. Yoshitomi H, Ishibashi T, Nakamura T, et al. Molecular epidemiologic analysis of the rhinovirus in Fukuoka. Annual report of the Fukuoka Institute of Health and Environmental Sciences. 2012;40:94-97. Japanese. Available at <http://www.fihes.pref.fukuoka.jp/~kikaku/Reports/Report40/pdf/np40letter4.pdf>. Accessed June 20, 2022.
3. 3. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare, Japan. Pathogens detected in cases of SARS-CoV-2 infection or suspected SARS-CoV-2 infection reported in National Epidemiological Surveillance of Infectious Disease (NESID), from January 2020 to December 2021. Infectious Agents Surveillance Report. Available at <https://www.niid.go.jp/niid/images/iasr/2021/12/502s01.gif>. Accessed June 20, 2022. Japanese.
4. 4. Haas LE, Thijsen SF, van Elden L, et al. Human metapneumovirus in adults. Viruses. 2013;5:87-110.
5. 5. Honda H, Iwahashi J, Kashiwagi T, et al. Outbreak of human metapneumovirus infection in eldery inpatients in Japan. J Am Geriatr Soc. 2006;54:177-180.